← Back to Search

Cetaphil Restoraderm for Atopic Dermatitis

N/A
Waitlist Available
Led By Eric Simpson, MD, MCR
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2, 6, 12, 18, and 24 months
Awards & highlights
No Placebo-Only Group

Summary

The goal of this study is to determine what effect Cetaphil® Restoraderm® system has on babies' skin versus Johnson \& Johnson baby lotion and skin cleanser.

Eligible Conditions
  • Atopic Dermatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2, 6, 12, 18, and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2, 6, 12, 18, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of Participants With Cumulative Atopic Dermatitis Diagnosed by Investigator at 12 Months
Secondary study objectives
Age at Onset of Eczema
Filaggrin Mutation Status
Percentage of High Emollient Use
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cetaphil RestoradermExperimental Treatment1 Intervention
Subjects will apply Cetaphil Restoraderm moisturizer once daily to infant's skin. They will bathe their infant with Cetaphil Restoraderm cleanser.
Group II: Standard of CareActive Control1 Intervention
Subjects will apply Johnson\&Johnson moisturizer to their infant's skin as often as they wish. They will also use the Johnson\&Johnson cleanser.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
1,006 Previous Clinical Trials
7,413,872 Total Patients Enrolled
Galderma R&DIndustry Sponsor
302 Previous Clinical Trials
60,587 Total Patients Enrolled
Eric Simpson, MD, MCRPrincipal InvestigatorOregon Health and Science University
2 Previous Clinical Trials
819 Total Patients Enrolled
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top